Manifold Investments has secured $18 million in Series B funding to enhance its AI platform dedicated to transforming life sciences research efficiency.

Information on the Target

Manifold Investments is an innovative AI platform designed specifically for the life sciences sector, aiming to streamline the research process from discovery to precision medicine. By integrating seamlessly with existing scientific and data infrastructures, Manifold seeks to enhance the efficiency at which researchers can access and analyze complex data sets. The company is currently led by CEO Vinay Seth Mohta and President Vivek Mohta, both of whom bring extensive experience in health data management and a strong commitment to accelerating scientific advancements.

Recently, Manifold secured $18 million in a Series B funding round, with support from prominent investors, including SilverArc Capital, Industry Ventures, TQ Ventures, and Calibrate Ventures. This capital will be utilized to further develop its Agent OS, a proprietary platform that combines data, analytical tools, and domain expertise, enabling scientists to convert their research questions into actionable insights more effectively.

Industry Overview in the Target’s Specific Country

The life sciences industry is experiencing significant evolution, marked by rapid advancements in genomics, imaging, and AI-enabled modeling. However, the rate of scientific breakthroughs is not keeping pace with the burgeoning availability of data